2017-2021 Europe Nucleic Acid Testing (NAT): France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Publisher Name :
Date: 18-Jan-2017
No. of pages: 1273

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.

This new 1,273-page comprehensive five-country report from VPGMarketResearch is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.  

Table of Contents

I.  Introduction

II. Worldwide Technology and Market Overview

     A.  DNA Sequencing
         
     B.  DNA and RNA Probes Technology
         
     C.  Detection Technologies
         
     D.  Instrumentation Review
           
     E.  Biochips: Genosensors, Microarrays, and Labs-on-the-Chip

     F.  Pharmacogenomics

     G.  Major Applications

III.France

IV.Germany

V. Italy

VI.Spain

VII.    U.K.

VIII.   Major Product Development Opportunities

IX.Design Criteria for Decentralized Testing Products

X. Alternative Market Penetration Strategies

XI.     Potential Market Entry Barriers and Risks

XII.    Competitive Assessments

XIII.   Appendix
                                                                  
Contains 1,273 pages and 139 tables

2017-2021 Europe Nucleic Acid Testing (NAT): France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Table of Contents

I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing
Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Market and Technology Review
A. DNA Sequencing
1. Introduction
2. Sequencing Methods
3. Autoradiography
4. The Human Genome Project
5. Sequencing Automation
6. Image Scanners
7. Fluorescent Detection
8. Gene Profiling
9. Gene Expression
10. Polymorphism Screening
11. Protein Interaction Networks
B. DNA and RNA Probe Technologies
1. Basic Principles
2. Probe Preparation
3. The DNA Probe Test
4. Test Formats
5. Labeling Techniques
6. Amplification Methods
C. Detection Technologies
1. Radioactive Methods
a. Overview
b. Major Isotopes
- P-32
- S-35
- H-3
- I-125
2. Non-Isotopic Methods
a. Enzymatic Labels
b. Chemical Labeling
- Indirect Chemical Labeling
- Direct Chemical Labeling
c. Fluorescence
d. Chemiluminescence
e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
1. Abbott LCx
2. Beckman Coulter/Biomek FK
3. BD Viper System with XTR Technology
4. BD Innova
5. Becton Dickinson SDA
6. bioMerieux NucliSENS easyMAG
7. bioMerieux NucliSENS easyQ and MiniMAG
8. Bio-Rad GeneScope
9. Cepheid GeneXpert
10. Curetis Unyvero
11. GenMark Dx eSensor XT-8
12. Hologic/Gen-Probe Panther
13. Hologic/Gen-Probe Tigris/DTS
14. HTG Molecular Edge
15. Life Technologies QuantStudio Dx
16. Qiagen QIAsymphony RGQ
17. Roche Cobas Amplicor
18. Roche Cobas TaqMan 48
19. Roche Cobas TaqMan
20. Roche Cobas TaqMan AmpliPrep
21. Roche LighCycler 480
22. Roche Cobas 4800
23. Roche Cobas s 201
24. Siemens Versant
25. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
- Liquid Transportation and Mixing
- Separation
- Reaction
- Detection
F. Pharmacogenomics
G. Major Applications
1. Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
- AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
- Adenovirus
- Aeromonas
- Anthrax/Bacillus Anthracis
- Arboviruses
- Babesiosis
- Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
- Blastocystis Hominis
- Brucella
- Campylobacter
- Candida
- Chagas Disease
- Chancroid
- Chlamydia
- Clostridium Difficile
- Coronaviruses
- Coxsackieviruses
- Creutzfeldt-Jakob's Disease
- Cryptosporidium Parvum
- Cyclospora Cayetanensis
- Cytomegalovirus
- Ebola Virus
- E. Coli
- EchoVirus
- Encephalitis
- Enteroviruses
- Epstein-Barr Virus
- Giardia Lamblia
- Gonorrhea
- Granuloma Inguinale
- Hantavirus
- Helicobacter Pylori
- Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
- Herpes Simplex Virus
- Human Herpes Virus-6 (HHV-6)
- Influenza Viruses
- Legionella
- Lyme Disease
- Lymphogranuloma Venereum (LGV)
- Malaria
- Measles (Rubeola)
- Meningitis
- Microsporidium
- Mononucleosis
- Mumps
- Mycoplasma
- Papillomaviruses
- Parvovirus B19
- Pneumonia
- Polyomaviruses
- Pseudomonas Aeruginosa
- Rabies
- Respiratory Syncytial Virus (RSV)
- Rhinoviruses
- Rotavirus
- Rubella
- Salmonellosis
- Septicemia
- Shigellosis
- Staphylococcus Aureus
- Streptococci
- Syphilis
- Toxoplasmosis
- Trichomonas Vaginalis
- Tuberculosis
- Vibrio
- West Nile Virus
- Yersina
2. Cancer Testing
a. Overview
b. Major Cancer Types
* Prostate
* Lung
* Colon and Rectum
* Breast
* Skin
* Uterine
* Leukemia
* Oral
c. Oncogenes
- Abl/abl-bcr
- AIB1
- BCL-2
- BRCA1
- CD44
- C-fos
- C-myb
- C-myc
- CYP17
- Erb-B
- HPC1
- N-myc
- P40
- P51
- P53
- PIK3CA
- PTI-1
- Ras
- Reg
- Sis
- Src
3. Genetic Diseases
a. Overview
b. Nucleic Acid Amplification
c. Chromosome Imaging
d. Genomics Technologies
e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases
* Achondroplasia
* Autosomal Dominant Polycystic Kidney
Disease
* Cancer
* Cosmetogenomics
* Cystic Fibrosis
* Down's Syndrome
* Duchenne and Becker Muscular Dystrophy
* Factor V (Leiden)
* Factor IX Deficiency
* Fragile X Syndrome
* Heart Disease
* Hemochomatosis
* Hemophilia
* Huntington's Disease
* Maternal-Fetal Incompatibility
* Multiple Endocrine Neoplasia
* Phenylketonuria (PKU)
* Polycystic Kidney Disease (PKD)
* Prenatal Screening
* Retinitis Pigmentosa
* Retinoblastoma
* Sickle Cell Anemia
* Spinal Muscular Atrophy
* Vitamin B12 Metabolism
i. Social Issues and Concerns
4. Forensic Testing
a. Overview
b. Multilocus and Single Locus Probes
* Multilocus Probes
* Single Locus Probes
* PCR and RFLP
c. The FBI
d. DNA Profile Data Banks
* U.S.A.
* U.K. e. Judicial Implementation
f. Major Crime Categories
g. Factors Contributing to the DNA Probe
Market Expansion
* Technology Availability
* Use of Hair as Evidence
h. Wildlife Forensics
5. Paternity Testing/HLA Typing
6. Other Applications
a. Disease Susceptibility Testing
b. Cardiovascular Diseases
c. Diabetes
d. Alzheimer's Disease
e. Periodontal Disease
f. Plasma Purification
g. Organ Transplantation
h. Water Contamination
i. Other
H. Competing/complementing
1. Monoclonal Antibodies/Immunoassays
2. RNA Probes
3. Two-Dimensional Electrophoresis
4. Flow Cytometry
VII. France Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
VIII. Germany Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
IX. Italy Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
X. Spain Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XI. U.K. Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XII. Competitive Assessments
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- CellMark Forensics/LabCorp
- Decode Genetics
- Diadexus
- Eiken
- Elitech Group
- Enzo
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech/Leica
- Li-Cor Biosciences
- Monogram Biosciences/LabCorp
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher
XIII. Appendix: Major Universities and Research Centers Developing Molecular Diagnostic Technologies

List of Tables

Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application In Cancer Diagnosis Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
France Molecular Diagnostics Test Volume And Sales by Major Application
France Laboratories Performing DNA Sequencing by Market Segment
France Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
France Molecular Diagnostics Test Volume by Major Application
France Major Infectious Disease Test Volume by Assay
France Major Infectious Disease Test Volume by Method
France Molecular Diagnostics Market by Major Application
France Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
France Major Infectious Disease Diagnostics Market by Assay
France AIDS Testing Market Estimated Sales by Major Supplier
France Adenovirus Testing Market Estimated Sales by Major Supplier
France Chlamydia Testing Market Estimated Sales by Major Supplier
France CMV Testing Market Estimated Sales by Major Supplier
France Gonorrhea Testing Market Estimated Sales by Major Supplier
France Hepatitis Testing Market Estimated Sales by Major Supplier
France Hepatitis C Testing Market Estimated Sales by Major Supplier
France HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
France Herpes Testing Market Estimated Sales by Major Supplier
France Influenza Testing Market Estimated Sales by Major Supplier
France Meningitis Testing Market Estimated Sales by Major Supplier
France Mycoplasma Testing Market Estimated Sales by Major Supplier
France RSV Testing Market Estimated Sales by Major Supplier
France Shigella Testing Market Estimated Sales by Major Supplier
Germany Molecular Diagnostics Test Volume And Sales by Major Application
Germany Laboratories Performing DNA Sequencing by Market Segment
Germany Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany Molecular Diagnostics Test Volume by Major Application
Germany Major Infectious Disease Test Volume by Assay
Germany Major Infectious Disease Test Volume by Method
Germany Molecular Diagnostics Market by Major Application
Germany Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Germany Major Infectious Disease Diagnostics Market by Assay
Germany AIDS Testing Market Estimated Sales by Major Supplier
Germany CMV Testing Market Estimated Sales by Major Supplier
Germany EBV Testing Market Estimated Sales by Major Supplier
Germany Gonorrhea Testing Market Estimated Sales by Major Supplier
Germany Hepatitis Testing Market Estimated Sales by Major Supplier
Germany Hepatitis C Testing Market Estimated Sales by Major Supplier
Germany HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Germany Herpes Testing Market Estimated Sales by Major Supplier
Germany Influenza Testing Market Estimated Sales by Major Supplier
Germany Meningitis Testing Market Estimated Sales by Major Supplier
Germany Mycoplasma Testing Market Estimated Sales by Major Supplier
Germany Pneumonia Testing Market Estimated Sales by Major Supplier
Germany RSV Testing Market Estimated Sales by Major Supplier
Germany Rotavirus Testing Market Estimated Sales by Major Supplier
Italy Molecular Diagnostics Test Volume And Sales by Major Application
Italy Laboratories Performing DNA Sequencing by Market Segment
Italy Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Italy Molecular Diagnostics Test Volume by Major Application
Italy Major Infectious Disease Test Volume by Assay
Italy Major Infectious Disease Test Volume by Method
Italy Molecular Diagnostics Market by Major Application
Italy Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Italy Major Infectious Disease Diagnostics Market by Assay
Italy AIDS Testing Market Estimated Sales by Major Supplier
Italy CMV Testing Market Estimated Sales by Major Supplier
Italy Gonorrhea Testing Market Estimated Sales by Major Supplier
Italy Hepatitis Testing Market Estimated Sales by Major Supplier
Italy Hepatitis C Testing Market Estimated Sales by Major Supplier
Italy HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Italy Herpes Testing Market Estimated Sales by Major Supplier
Italy Influenza Testing Market Estimated Sales by Major Supplier
Italy Meningitis Testing Market Estimated Sales by Major Supplier
Italy Mycoplasma Testing Market Estimated Sales by Major Supplier
Italy RSV Testing Market Estimated Sales by Major Supplier
Spain Molecular Diagnostics Test Volume And Sales by Major Application
Spain Laboratories Performing DNA Sequencing by Market Segment
Spain Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Spain Molecular Diagnostics Test Volume by Major Application
Spain Major Infectious Disease Test Volume by Assay
Spain Major Infectious Disease Test Volume by Method
Spain Molecular Diagnostics Market by Major Application
Spain Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Spain Major Infectious Disease Diagnostics Market by Assay
Spain AIDS Testing Market Estimated Sales by Major Supplier
Spain Chlamydia Testing Market Estimated Sales by Major Supplier
Spain CMV Testing Market Estimated Sales by Major Supplier
Spain Gonorrhea Testing Market Estimated Sales by Major Supplier
Spain Hepatitis Testing Market Estimated Sales by Major Supplier
Spain Hepatitis C Testing Market Estimated Sales by Major Supplier
Spain HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Spain Herpes Testing Market Estimated Sales by Major Supplier
Spain Influenza Testing Market Estimated Sales by Major Supplier
Spain Meningitis Testing Market Estimated Sales by Major Supplier
Spain Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Molecular Diagnostics Test Volume And Sales by Major Application
U.K. Laboratories Performing DNA Sequencing by Market Segment
U.K. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K. Molecular Diagnostics Test Volume by Major Application
U.K. Major Infectious Disease Test Volume by Assay
U.K. Major Infectious Disease Test Volume by Method
U.K. Molecular Diagnostics Market by Major Application
U.K. Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
U.K. Major Infectious Disease Diagnostics Market by Assay
U.K. AIDS Testing Market Estimated Sales by Major Supplier
U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K. Influenza Testing Market Estimated Sales by Major Supplier
U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Pneumonia Testing Market Estimated Sales by Major Supplier
U.K. Shigella Testing Market Estimated Sales by Major Supplier
  • Global Vitamin D Testing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 98
    Vitamin D is vital for strong bones. It also has important, emerging roles in immune function and cancer prevention. Deficiencies at any stage of life can have devastating consequences. Similarly, vitamin D toxicity resulting from overmedication can cause serious hyperkalemia. Vitamin D consists of two bioequivalent forms: Vitamin D2: obtained from vegetable sources (dietary sources, supplements) Vitamin D3: derived from both endogenous (synthesized from cholesterol through sun expos......
  • Global Vitamin D Testing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122
    According to our LPI (LP Information) latest study, the global Vitamin D Testing market size was valued at US$ million in 2023. With growing demand in downstream market, the Vitamin D Testing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Vitamin D Testing market. Vitamin D Testing are expected to show stable growth in the future market. However, product differentiation, reduc......
  • Global C-Reactive Protein Test (CRP) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global C-Reactive Protein Test (CRP) market size was valued at US$ 646 million in 2023. With growing demand in downstream market, the C-Reactive Protein Test (CRP) is forecast to a readjusted size of US$ 985.9 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global C-Reactive Protein Test (CRP) market. C-Reactive Protein Test (CRP) are expected to show stable growth......
  • Global Blood Culture Test Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113
    According to our LPI (LP Information) latest study, the global Blood Culture Test market size was valued at US$ million in 2023. With growing demand in downstream market, the Blood Culture Test is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Blood Culture Test market. Blood Culture Test are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Vitamin D Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Vitamin D Testing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Vitamin D is vital for strong bones. It also has important, emerging roles in immune function and cancer prevention. Deficiencies at any stage of life can have devastating consequences. Similarly, vitamin D toxicity resulting from overmedication can cause serious ......
  • Global Blood Culture Test Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 110
    According to our (Global Info Research) latest study, the global Blood Culture Test market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Blood cultures are used to detect the presence of bacteria or fungi in the blood, to identify the type present, and to guide treatment. Testing is used to identify a blood infection (septicemia) that can lead to sepsis, a serious and life-threatening complication......
  • Global Liquid Biopsy Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 100
    A liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, primarily blood. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advance......
  • Global Liquid Biopsy Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, primarily blood. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advance......
  • Global Automatic Immunohematology Analyzer Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 103
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs